Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

Description

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

This Product Explainer is supported by CSL Seqirus

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Jeremy Grummet

A/Prof Jeremy Grummet

PSA Testing Demystified

Clinical A/Prof Lauren Sanders

Clinical A/Prof Lauren Sanders

Migraine Management Update

Dr Johanna Lynch

Dr Johanna Lynch

Trauma-Informed Care in GP

Prof Richard O'Brien

Prof Richard O'Brien

Prevention and Management of Diabetic Retinopathy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Richard Harvey

expert

Prof Richard Harvey

Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon

Date published: 24 October 2023